A Simple Prognostic Benefit Scoring System for Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis...

Area of Science:

• Oncology
• Surgical Oncology
• Pulmonary Medicine

Background:

• Pulmonary metastasectomy is a treatment for sarcoma with lung metastases, but outcome prediction criteria are lacking.
• Establishing a prognostic scoring system is crucial for guiding treatment decisions.

Purpose of the Study:

• To develop a prognostic scoring system for sarcoma patients with pulmonary metastases.
• To identify preoperative prognostic factors influencing 3-year mortality.

Main Methods:

• Retrospective cohort study of 135 sarcoma patients undergoing pulmonary metastasectomy.
• Multivariable logistic regression analysis to identify predictors of 3-year mortality.
• Development and validation of the Sarcoma Lung Metastasis Score.

Main Results:

• Key predictors identified: disease-free interval (≥2 years), maximum tumor diameter (≥15 mm), and number of metastases (≥6).
• The Sarcoma Lung Metastasis Score (0-3 points) demonstrated strong correlation with 3-year survival rates (89.5% to 10.5%).

Conclusions:

• The proposed Sarcoma Lung Metastasis Score is a simple and effective prognostic tool.
• This score can assist clinicians in selecting optimal treatments for sarcoma patients with pulmonary metastases.